Leukos Biotech

Leukos biotech email format

Verified email-pattern data for Leukos Biotech is currently limited. You can still use the company insights and contact sections below.
Leukos Biotech is a biopharmaceutical company focused on the development of new treatments for Acute Myeloid Leukaemia and other haematological malignancies. The company was founded in 2015 as a spin-off from the Josep Carreras Leukaemia Research Institute (IJC) and has a strong scientific, institutional and economic support from the IJC and the Josep Carreras Leukaemia Foundation, among other partners and collaborators. The company has closed a licensing agreement with the Austrian pharmaceutical company AOP-Health to develop LB208, the first clinical candidate, in oncological indications starting with haematological tumors. Leukos, together with VHIR and Leitat, received in November 2022 a 1,4M€ grant/loan (CPP2021-008715) investigate further the mechanism of action of LB208, a tumor-specific oral HTR1B antagonist, and to perform an exploratory clinical trial

Company Details

Employees
5
Founded
-
Address
Muntaner 383, 3º 2ª, Barcelona,spain
Phone
34931998148
Industry
Pharmaceutical Manufacturing
HQ
Barcelona
Looking for a particular Leukos Biotech employee's phone or email?

Leukos Biotech Questions

Explore related pages

Related company profiles:

Top Leukos Biotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant